Validation of Cadherin HAV6 Peptide in the Transient Modulation of the Blood-Brain Barrier for the Treatment of Brain Tumors

The blood-brain barrier (BBB) poses a major obstacle by preventing potential therapeutic agents from reaching their intended brain targets at sufficient concentrations. While transient disruption of the BBB has been used to enhance chemotherapeutic efficacy in treating brain tumors, limitations in t...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Pharmaceutics
Main Authors: Sajesh, Babu V., On, Ngoc H., Omar, Refaat, Alrushaid, Samaa, Kopec, Brian M., Wang, Wei-Guang, Sun, Han-Dong, Lillico, Ryan, Lakowski, Ted M., Siahaan, Teruna J., Davies, Neal M., Puno, Pema-Tenzin, Vanan, Magimairajan Issai, Miller, Donald W.
Formato: Artigo
Idioma:Inglês
Publicado: MDPI 2019
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6781504/
https://ncbi.nlm.nih.gov/pubmed/31533285
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics11090481
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares